The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Hospital Acquired Infection Control market was valued at US$ 5702.2 million in 2023 and is anticipated to reach US$ 6985.5 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
North American market for Hospital Acquired Infection Control is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Hospital Acquired Infection Control is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Hospital Acquired Infection Control include Pfizer, Roche, Merck, Johnson & Johnson, Abott, Bayer, BD, Kimberly-Clark and Nordion, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Hospital Acquired Infection Control, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital Acquired Infection Control.
Report Scope
The Hospital Acquired Infection Control market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hospital Acquired Infection Control market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital Acquired Infection Control manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Pfizer
- Roche
- Merck
- Johnson & Johnson
- Abott
- Bayer
- BD
- Kimberly-Clark
- Nordion
- Cepheid
Segment by Type
- Catheter-associated Urinary Tract Infections (CAUTIs)
- Surgical Site Infections (SSIs)
- Central Line-associated Bloodstream Infections (CLABSIs)
- Respiratory Infections
Segment by Application
- Hospitals and ICUs
- Outpatient Care Centers
- Long-term Care Facilities (LTCFs)
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hospital Acquired Infection Control manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hospital Acquired Infection Control in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Hospital Acquired Infection Control Market Overview
1.1 Product Overview and Scope of Hospital Acquired Infection Control
1.2 Hospital Acquired Infection Control Segment by Type
1.2.1 Global Hospital Acquired Infection Control Market Value Comparison by Type (2024-2030)
1.2.2 Catheter-associated Urinary Tract Infections (CAUTIs)
1.2.3 Surgical Site Infections (SSIs)
1.2.4 Central Line-associated Bloodstream Infections (CLABSIs)
1.2.5 Respiratory Infections
1.3 Hospital Acquired Infection Control Segment by Application
1.3.1 Global Hospital Acquired Infection Control Market Value by Application: (2024-2030)
1.3.2 Hospitals and ICUs
1.3.3 Outpatient Care Centers
1.3.4 Long-term Care Facilities (LTCFs)
1.4 Global Hospital Acquired Infection Control Market Size Estimates and Forecasts
1.4.1 Global Hospital Acquired Infection Control Revenue 2019-2030
1.4.2 Global Hospital Acquired Infection Control Sales 2019-2030
1.4.3 Global Hospital Acquired Infection Control Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hospital Acquired Infection Control Market Competition by Manufacturers
2.1 Global Hospital Acquired Infection Control Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hospital Acquired Infection Control Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hospital Acquired Infection Control Average Price by Manufacturers (2019-2024)
2.4 Global Hospital Acquired Infection Control Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hospital Acquired Infection Control, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hospital Acquired Infection Control, Product Type & Application
2.7 Hospital Acquired Infection Control Market Competitive Situation and Trends
2.7.1 Hospital Acquired Infection Control Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hospital Acquired Infection Control Players Market Share by Revenue
2.7.3 Global Hospital Acquired Infection Control Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hospital Acquired Infection Control Retrospective Market Scenario by Region
3.1 Global Hospital Acquired Infection Control Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hospital Acquired Infection Control Global Hospital Acquired Infection Control Sales by Region: 2019-2030
3.2.1 Global Hospital Acquired Infection Control Sales by Region: 2019-2024
3.2.2 Global Hospital Acquired Infection Control Sales by Region: 2025-2030
3.3 Global Hospital Acquired Infection Control Global Hospital Acquired Infection Control Revenue by Region: 2019-2030
3.3.1 Global Hospital Acquired Infection Control Revenue by Region: 2019-2024
3.3.2 Global Hospital Acquired Infection Control Revenue by Region: 2025-2030
3.4 North America Hospital Acquired Infection Control Market Facts & Figures by Country
3.4.1 North America Hospital Acquired Infection Control Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hospital Acquired Infection Control Sales by Country (2019-2030)
3.4.3 North America Hospital Acquired Infection Control Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hospital Acquired Infection Control Market Facts & Figures by Country
3.5.1 Europe Hospital Acquired Infection Control Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hospital Acquired Infection Control Sales by Country (2019-2030)
3.5.3 Europe Hospital Acquired Infection Control Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hospital Acquired Infection Control Market Facts & Figures by Country
3.6.1 Asia Pacific Hospital Acquired Infection Control Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hospital Acquired Infection Control Sales by Country (2019-2030)
3.6.3 Asia Pacific Hospital Acquired Infection Control Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hospital Acquired Infection Control Market Facts & Figures by Country
3.7.1 Latin America Hospital Acquired Infection Control Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hospital Acquired Infection Control Sales by Country (2019-2030)
3.7.3 Latin America Hospital Acquired Infection Control Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hospital Acquired Infection Control Market Facts & Figures by Country
3.8.1 Middle East and Africa Hospital Acquired Infection Control Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hospital Acquired Infection Control Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hospital Acquired Infection Control Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hospital Acquired Infection Control Sales by Type (2019-2030)
4.1.1 Global Hospital Acquired Infection Control Sales by Type (2019-2024)
4.1.2 Global Hospital Acquired Infection Control Sales by Type (2025-2030)
4.1.3 Global Hospital Acquired Infection Control Sales Market Share by Type (2019-2030)
4.2 Global Hospital Acquired Infection Control Revenue by Type (2019-2030)
4.2.1 Global Hospital Acquired Infection Control Revenue by Type (2019-2024)
4.2.2 Global Hospital Acquired Infection Control Revenue by Type (2025-2030)
4.2.3 Global Hospital Acquired Infection Control Revenue Market Share by Type (2019-2030)
4.3 Global Hospital Acquired Infection Control Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hospital Acquired Infection Control Sales by Application (2019-2030)
5.1.1 Global Hospital Acquired Infection Control Sales by Application (2019-2024)
5.1.2 Global Hospital Acquired Infection Control Sales by Application (2025-2030)
5.1.3 Global Hospital Acquired Infection Control Sales Market Share by Application (2019-2030)
5.2 Global Hospital Acquired Infection Control Revenue by Application (2019-2030)
5.2.1 Global Hospital Acquired Infection Control Revenue by Application (2019-2024)
5.2.2 Global Hospital Acquired Infection Control Revenue by Application (2025-2030)
5.2.3 Global Hospital Acquired Infection Control Revenue Market Share by Application (2019-2030)
5.3 Global Hospital Acquired Infection Control Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Hospital Acquired Infection Control Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Roche Hospital Acquired Infection Control Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Hospital Acquired Infection Control Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Hospital Acquired Infection Control Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Abott
6.5.1 Abott Corporation Information
6.5.2 Abott Description and Business Overview
6.5.3 Abott Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Abott Hospital Acquired Infection Control Product Portfolio
6.5.5 Abott Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Corporation Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bayer Hospital Acquired Infection Control Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 BD
6.6.1 BD Corporation Information
6.6.2 BD Description and Business Overview
6.6.3 BD Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BD Hospital Acquired Infection Control Product Portfolio
6.7.5 BD Recent Developments/Updates
6.8 Kimberly-Clark
6.8.1 Kimberly-Clark Corporation Information
6.8.2 Kimberly-Clark Description and Business Overview
6.8.3 Kimberly-Clark Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Kimberly-Clark Hospital Acquired Infection Control Product Portfolio
6.8.5 Kimberly-Clark Recent Developments/Updates
6.9 Nordion
6.9.1 Nordion Corporation Information
6.9.2 Nordion Description and Business Overview
6.9.3 Nordion Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Nordion Hospital Acquired Infection Control Product Portfolio
6.9.5 Nordion Recent Developments/Updates
6.10 Cepheid
6.10.1 Cepheid Corporation Information
6.10.2 Cepheid Description and Business Overview
6.10.3 Cepheid Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Cepheid Hospital Acquired Infection Control Product Portfolio
6.10.5 Cepheid Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hospital Acquired Infection Control Industry Chain Analysis
7.2 Hospital Acquired Infection Control Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hospital Acquired Infection Control Production Mode & Process
7.4 Hospital Acquired Infection Control Sales and Marketing
7.4.1 Hospital Acquired Infection Control Sales Channels
7.4.2 Hospital Acquired Infection Control Distributors
7.5 Hospital Acquired Infection Control Customers
8 Hospital Acquired Infection Control Market Dynamics
8.1 Hospital Acquired Infection Control Industry Trends
8.2 Hospital Acquired Infection Control Market Drivers
8.3 Hospital Acquired Infection Control Market Challenges
8.4 Hospital Acquired Infection Control Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
